Edited by Pablo Figueroa, Partner, Pérez Llorca and Lecturer, Queen Mary University, London, UK and Alejandro Guerrero, Of Counsel, Gibson, Dunn & Crutcher LLP, Belgium

‘The topics are very interesting, the contributions are well researched and practical in their approach and are very readable in style. A must-have book for academics and practitioners involved in the pharmaceutical sector.’

• Contents:1. Competition Law and Pharma: An Economic PerspectiveBenoît Durand2. Reverse Payments: an EU and U.S. PerspectiveFrank Maier-Rigaud, Nathan Blalock and Oliver Gannon3. Article 101 TFEU: Horizontal Cooperation Agreements in the Pharmaceutical SectorSoledad Blanco Thomas, Lilia Luchianov and Thomas Weck4. The Competitive Assessment of IP Licensing Agreements in the Pharmaceutical SectorPierre Moullet5. Article 102 TFEU: Patent filings as an abuse of dominant position after “AstraZeneca”: the patent / antitrust interface under a new perspectiveFrancisco Hernández6. Mergers in the Pharmaceutical SectorPablo Figueroa and Alejandro Guerrero7. Mergers in the Medical Devices SectorJan Heithecker8. Antitrust Practices in Pharmaceutical Public ProcurementAntonio Minho López9. EU Trade Law and PharmaceuticalsPascale Hecker10. The Pharmaceutical Sector and Parallel TradeEdurne Navarro Varona and Cristina Caballero11. Free Movement and Competition in the European Market for PharmaceuticalsPedro Caro de Sousa12. IP Law and Pharmaceuticals: Patents and Supplementary Protection Certificates in the Pharmaceutical SectorRais Amils13. The EU Regulatory Framework for Medical Products for Human UseMarc Martens and Nicolas Carbonnelle14. Antitrust and the Pharmaceutical Industry in the United StatesGeorge A. Hay15. UK Competition and Trade in the Pharma SectorPaula Riedel16. Competition law and Pharma: ChinaAndrew Foster17. Competition Law and Pharma: SpainHelmut Brokelmann and Mariarosaria Ganino18. The Application of Competition Law in the Pharmaceutical Sector: Challenges for BRICS Maria Ioannidou and Ioannis Kokkoris19. Product Hopping: The U.S. ApproachMichael A. Carrier20. Marketing data in the Pharmaceutical Sector: a competition law considerationPedro CallolIndex

Edited by Pablo Figueroa, Partner, Pérez Llorca and Lecturer, Queen Mary University, London, UK and Alejandro Guerrero, Of Counsel, Gibson, Dunn & Crutcher LLP, Belgium

‘The topics are very interesting, the contributions are well researched and practical in their approach and are very readable in style. A must-have book for academics and practitioners involved in the pharmaceutical sector.’

• Contents:1. Competition Law and Pharma: An Economic PerspectiveBenoît Durand2. Reverse Payments: an EU and U.S. PerspectiveFrank Maier-Rigaud, Nathan Blalock and Oliver Gannon3. Article 101 TFEU: Horizontal Cooperation Agreements in the Pharmaceutical SectorSoledad Blanco Thomas, Lilia Luchianov and Thomas Weck4. The Competitive Assessment of IP Licensing Agreements in the Pharmaceutical SectorPierre Moullet5. Article 102 TFEU: Patent filings as an abuse of dominant position after “AstraZeneca”: the patent / antitrust interface under a new perspectiveFrancisco Hernández6. Mergers in the Pharmaceutical SectorPablo Figueroa and Alejandro Guerrero7. Mergers in the Medical Devices SectorJan Heithecker8. Antitrust Practices in Pharmaceutical Public ProcurementAntonio Minho López9. EU Trade Law and PharmaceuticalsPascale Hecker10. The Pharmaceutical Sector and Parallel TradeEdurne Navarro Varona and Cristina Caballero11. Free Movement and Competition in the European Market for PharmaceuticalsPedro Caro de Sousa12. IP Law and Pharmaceuticals: Patents and Supplementary Protection Certificates in the Pharmaceutical SectorRais Amils13. The EU Regulatory Framework for Medical Products for Human UseMarc Martens and Nicolas Carbonnelle14. Antitrust and the Pharmaceutical Industry in the United StatesGeorge A. Hay15. UK Competition and Trade in the Pharma SectorPaula Riedel16. Competition law and Pharma: ChinaAndrew Foster17. Competition Law and Pharma: SpainHelmut Brokelmann and Mariarosaria Ganino18. The Application of Competition Law in the Pharmaceutical Sector: Challenges for BRICS Maria Ioannidou and Ioannis Kokkoris19. Product Hopping: The U.S. ApproachMichael A. Carrier20. Marketing data in the Pharmaceutical Sector: a competition law considerationPedro CallolIndex